Indicators

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Sanofi to offer insulin product for $35 to all Americans through GoodRx

October 19, 2023

'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles

October 14, 2023

Novo Nordisk hikes outlook on soaring demand for Wegovy, Ozempic

October 13, 2023

Tempest Therapeutics, Microsoft, Birkenstock, Novo Nordisk, Tesla: Why These 5 Stocks Are On Investors' Radars Today

October 11, 2023

How is the rise of GLP-1 weight loss drugs affecting market action? Jim Cramer explains

October 11, 2023

Stocks making the biggest moves midday: Novo Nordisk, DaVita, Exxon Mobil, Amgen and more

October 11, 2023

Stocks making the biggest moves premarket: Plug Power, Exxon Mobil, Pioneer, Novo Nordisk and more

October 11, 2023

LVMH shares fall to 2023 low as growth slows, pulling luxury sector down

October 11, 2023

How Ozempic and Wegovy turned Novo Nordisk into a $400 billion company

October 10, 2023

Here are 20 stocks I'm watching Tuesday, including Lilly, AMD and Goldman Sachs

October 10, 2023

Weight loss drugs may be linked to stomach paralysis, other rare but severe issues, study says

October 05, 2023

Here are 18 stocks I am watching in the market, including Clorox, Rivian and Airbnb

October 05, 2023

Drugmakers opt in to Medicare drug price negotiations – here's what happens next

October 02, 2023

Big Food vs. Big Pharma: Companies bet on snacking just as weight loss drugs boom

October 01, 2023

Shares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill data

September 29, 2023

Ad spending for obesity, diabetes drugs is soaring this year, as drugmakers shell out nearly $500 million

September 29, 2023

Ozempic, Wegovy drug prescriptions hit 9 million, surge 300% in under three years

September 27, 2023

Eli Lilly sues clinics allegedly selling knockoff versions of Mounjaro diabetes drug

September 19, 2023

Here's why Jim Cramer likes J.M. Smucker's plan to buy the maker of Twinkies

September 11, 2023

Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here's what we know

September 10, 2023

Big pharma's blockbuster obesity drug battle is just getting started, and it's headed for $100 billion

September 09, 2023

Blockbuster weight loss drugs Wegovy and Ozempic are being tested to treat addiction and dementia

September 07, 2023

Stocks making the biggest moves premarket: Enbridge, Roku, Gitlab and more

September 06, 2023

Novo Nordisk's Wegovy weight loss drug launches in the UK

September 04, 2023

Weight loss drugmaker Novo Nordisk vies to become Europe's most valuable company, toppling LVMH

September 01, 2023

5 things to know before the stock market opens Friday

September 01, 2023

Ozempic could be the next target of Medicare drug price negotiations – here's why

August 31, 2023

Wegovy helps reduce heart failure symptoms in obese people, study says

August 25, 2023

Weight loss drugs boost sales at retail pharmacies, but they may not help profits much

August 21, 2023

Weight loss drugs are priced substantially higher in the U.S. than in other countries, analysis says

August 17, 2023

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.